These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 12084557)

  • 1. Transient biochemical response in interferon therapy decreases the development of hepatocellular carcinoma for five years and improves the long-term survival of chronic hepatitis C patients.
    Okanoue T; Itoh Y; Kirishima T; Daimon Y; Toyama T; Morita A; Nakajima T; Minami M
    Hepatol Res; 2002 May; 23(1):62-77. PubMed ID: 12084557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferon therapy lowers the rate of progression to hepatocellular carcinoma in chronic hepatitis C but not significantly in an advanced stage: a retrospective study in 1148 patients. Viral Hepatitis Therapy Study Group.
    Okanoue T; Itoh Y; Minami M; Sakamoto S; Yasui K; Sakamoto M; Nishioji K; Murakami Y; Kashima K
    J Hepatol; 1999 Apr; 30(4):653-9. PubMed ID: 10207807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of interferon therapy on the incidence of hepatocellular carcinoma and mortality of patients with chronic hepatitis C: a retrospective cohort study of 738 patients.
    Tanaka H; Tsukuma H; Kasahara A; Hayashi N; Yoshihara H; Masuzawa M; Kanda T; Kashiwagi T; Inoue A; Kato M; Oshima A; Kinoshita Y; Kamada T
    Int J Cancer; 2000 Sep; 87(5):741-9. PubMed ID: 10925370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retreatment with interferon-alpha at dosages or period increased by 1.3 times is effective for treatment for transient responders and non-responders in chronic hepatitis C patients.
    Okanoue T; Daimon Y; Kirishima T; Ohnishi N; Nakamura H; Nagao Y; Minami M; Itoh Y
    Hepatol Res; 2001 Jul; 20(3):348-358. PubMed ID: 11404194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term follow-up of sustained responders to interferon therapy, in patients with chronic hepatitis C.
    Toyoda H; Kumada T; Tokuda A; Horiguchi Y; Nakano H; Honda T; Nakano S; Hayashi K; Katano Y; Nakano I; Hayakawa T; Nishimura D; Kato K; Imada K; Imoto M; Fukuda Y;
    J Viral Hepat; 2000 Nov; 7(6):414-9. PubMed ID: 11115052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term responders without eradication of hepatitis C virus after interferon therapy: characterization of clinical profiles and incidence of hepatocellular carcinoma.
    Yabuuchi I; Imai Y; Kawata S; Tamura S; Noda S; Inada M; Maeda Y; Shirai Y; Fukuzaki T; Kaji I; Ishikawa H; Matsuda Y; Nishikawa M; Seki K; Matsuzawa Y
    Liver; 2000 Jul; 20(4):290-5. PubMed ID: 10959807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased risk of hepatocellular carcinoma in patients with chronic hepatitis C whose serum alanine aminotransferase levels became less than twice the upper limit of normal following interferon therapy.
    Moriyama M; Matsumura H; Aoki H; Shimizu T; Yamagami H; Shioda A; Kaneko M; Goto I; Tanaka N; Arakawa Y
    Liver Int; 2005 Feb; 25(1):85-90. PubMed ID: 15698403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term evaluation of interferon therapy in hepatitis C virus-associated cirrhosis: does IFN prevent development of hepatocellular carcinoma?
    Tanaka K; Sata M; Uchimura Y; Suzuki H; Tanikawa K
    Oncol Rep; 1998; 5(1):205-8. PubMed ID: 9458323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of interferon alpha-2b plus ribavirin therapy on incidence of hepatocellular carcinoma in patients with chronic hepatitis.
    Kurokawa M; Hiramatsu N; Oze T; Mochizuki K; Yakushijin T; Kurashige N; Inoue Y; Igura T; Imanaka K; Yamada A; Oshita M; Hagiwara H; Mita E; Ito T; Inui Y; Hijioka T; Yoshihara H; Inoue A; Imai Y; Kato M; Kiso S; Kanto T; Takehara T; Kasahara A; Hayashi N
    Hepatol Res; 2009 May; 39(5):432-8. PubMed ID: 19207583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for hepatocellular carcinoma in hepatitis C patients with normal alanine aminotransferase treated with pegylated interferon and ribavirin.
    Harada N; Hiramatsu N; Oze T; Morishita N; Yamada R; Hikita H; Miyazaki M; Yakushijin T; Miyagi T; Yoshida Y; Tatsumi T; Kanto T; Kasahara A; Oshita M; Mita E; Hagiwara H; Inui Y; Katayama K; Tamura S; Yoshihara H; Imai Y; Inoue A; Hayashi N; Takehara T
    J Viral Hepat; 2014 May; 21(5):357-65. PubMed ID: 24716638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term outcome after interferon therapy in elderly patients with chronic hepatitis C.
    Arase Y; Ikeda K; Suzuki F; Suzuki Y; Saitoh S; Kobayashi M; Akuta N; Someya T; Koyama R; Hosaka T; Sezaki H; Kobayashi M; Kumada H
    Intervirology; 2007; 50(1):16-23. PubMed ID: 17164553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term outcome, with monitoring of platelet counts, in patients with chronic hepatitis C and liver cirrhosis after interferon therapy.
    Moriyama M; Matsumura H; Aoki H; Shimizu T; Nakai K; Saito T; Yamagami H; Shioda A; Kaneko M; Goto I; Tanaka N; Arakawa Y
    Intervirology; 2003; 46(5):296-307. PubMed ID: 14555850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic effect of response to interferon therapy after laparoscopic splenectomy among patients with marked thrombocytopenia and hepatitis C virus-related cirrhosis.
    Tamai H; Mori Y; Shingaki N; Shimizu R; Nuta J; Moribata K; Maeda Y; Muraki Y; Deguchi H; Inoue I; Maekita T; Iguchi M; Kato J; Takifuji K; Yamaue H; Ichinose M
    Hepatol Int; 2015 Jan; 9(1):67-75. PubMed ID: 25788381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A sustained virological response to interferon or interferon/ribavirin reduces hepatocellular carcinoma and improves survival in chronic hepatitis C: a nationwide, multicentre study in Taiwan.
    Yu ML; Lin SM; Chuang WL; Dai CY; Wang JH; Lu SN; Sheen IS; Chang WY; Lee CM; Liaw YF
    Antivir Ther; 2006; 11(8):985-94. PubMed ID: 17302368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatocellular carcinoma development in sustained viral responders to interferon therapy in patients with chronic hepatitis C.
    Enokimura N; Shiraki K; Kawakita T; Saitou Y; Inoue H; Okano H; Yamamoto N; Deguchi M; Sakai T; Ohmori S; Fujikawa K; Murata K; Niki Y; Nakano T
    Anticancer Res; 2003; 23(1B):593-6. PubMed ID: 12680152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Second hepatectomy for recurrent hepatocellular carcinoma achieved sustained virological response to interferon therapy for hepatitis C.
    Tsujita E; Yamashita Y; Takeishi K; Maeda T; Takaki S; Mori N; Aisaka Y; Furukawa Y; Shirabe K; Ishida T; Maehara Y
    Hepatogastroenterology; 2013; 60(128):2048-54. PubMed ID: 24088310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of serum HCV RNA at week 4 of interferon-alpha therapy is associated with more favorable long-term response in patients with chronic hepatitis C.
    Orito E; Mizokami M; Suzuki K; Ohba K; Ohno T; Mori M; Hayashi K; Kato K; Iino S; Lau JY
    J Med Virol; 1995 Jun; 46(2):109-15. PubMed ID: 7636496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of interferon on incidence of hepatocellular carcinoma in patients with chronic hepatitis C.
    Soga K; Shibasaki K; Aoyagi Y
    Hepatogastroenterology; 2005; 52(64):1154-8. PubMed ID: 16001651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural course of asymptomatic hepatitis C virus-infected patients and hepatocellular carcinoma after interferon therapy.
    Okanoue T; Minami M; Makiyama A; Sumida Y; Yasui K; Itoh Y
    Clin Gastroenterol Hepatol; 2005 Oct; 3(10 Suppl 2):S89-91. PubMed ID: 16234069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphoblastoid interferon alfa-n1 improves the long-term response to a 6-month course of treatment in chronic hepatitis C compared with recombinant interferon alfa-2b: results of an international randomized controlled trial. Clinical Advisory Group for the Hepatitis C Comparative Study.
    Farrell GC; Bacon BR; Goldin RD
    Hepatology; 1998 Apr; 27(4):1121-7. PubMed ID: 9537453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.